| Dr Ryan Michael Smith, MD | |
|
400 N State Of Franklin Rd, Johnson City, TN 37604 | |
| (423) 431-6111 | |
| Not Available |
| Full Name | Dr Ryan Michael Smith |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 400 N State Of Franklin Rd, Johnson City, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417336157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 58004 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johnson City Medical Center | Johnson city, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri-cities Observation Services, Pc | 3274819719 | 13 |
| Tri-cities Regional Emergency Physicians, Pc | 3678859477 | 129 |
News Archive
A recent study, published in Stem Cells Translational Medicine, explores the safety and efficacy of stem cells, which have been touted as the panacea for a wide range of illnesses, ranging from chronic degenerative conditions to cancer.
Taking blood stem cells collected from an umbilical cord into the lab and expanding their number before transplanting them to replace a patient's blood supply is as safe as a standard cord blood transplant, researchers reported at the 50th Annual Meeting of the American Society of Hematology.
A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cells—so-called induced pluripotent stem (iPS) cells—and found that relatively few genetic changes occur during stem cell conversion by an improved method.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
› Verified 6 days ago
| Entity Name | Tri-cities Regional Emergency Physicians, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063950046 PECOS PAC ID: 3678859477 Enrollment ID: O20170410002399 |
News Archive
A recent study, published in Stem Cells Translational Medicine, explores the safety and efficacy of stem cells, which have been touted as the panacea for a wide range of illnesses, ranging from chronic degenerative conditions to cancer.
Taking blood stem cells collected from an umbilical cord into the lab and expanding their number before transplanting them to replace a patient's blood supply is as safe as a standard cord blood transplant, researchers reported at the 50th Annual Meeting of the American Society of Hematology.
A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cells—so-called induced pluripotent stem (iPS) cells—and found that relatively few genetic changes occur during stem cell conversion by an improved method.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
› Verified 6 days ago
| Entity Name | Tri-cities Observation Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154860146 PECOS PAC ID: 3274819719 Enrollment ID: O20170417001080 |
News Archive
A recent study, published in Stem Cells Translational Medicine, explores the safety and efficacy of stem cells, which have been touted as the panacea for a wide range of illnesses, ranging from chronic degenerative conditions to cancer.
Taking blood stem cells collected from an umbilical cord into the lab and expanding their number before transplanting them to replace a patient's blood supply is as safe as a standard cord blood transplant, researchers reported at the 50th Annual Meeting of the American Society of Hematology.
A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cells—so-called induced pluripotent stem (iPS) cells—and found that relatively few genetic changes occur during stem cell conversion by an improved method.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan Michael Smith, MD 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Dr Ryan Michael Smith, MD 400 N State Of Franklin Rd, Johnson City, TN 37604 Ph: (423) 431-6111 |
News Archive
A recent study, published in Stem Cells Translational Medicine, explores the safety and efficacy of stem cells, which have been touted as the panacea for a wide range of illnesses, ranging from chronic degenerative conditions to cancer.
Taking blood stem cells collected from an umbilical cord into the lab and expanding their number before transplanting them to replace a patient's blood supply is as safe as a standard cord blood transplant, researchers reported at the 50th Annual Meeting of the American Society of Hematology.
A team of researchers from Johns Hopkins University and the National Human Genome Research Institute has evaluated the whole genomic sequence of stem cells derived from human bone marrow cells—so-called induced pluripotent stem (iPS) cells—and found that relatively few genetic changes occur during stem cell conversion by an improved method.
Retinoic acid (RA), a natural derivative of vitamin A, is the basis of a number of treatments against cancer. Nevertheless, it has certain disadvantages, such as the possibility of the appearance of retinoic acid syndrome, present in 25 % of cases and which can lead to death. The development of 4-HPR, a synthetic derivative of RA, has meant a considerable advance due to its greater efficacy compared to its predecessor.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
› Verified 6 days ago
Tony Yost, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 378 Marketplace Dr, Suite 5, Johnson City, TN 37604 Phone: 423-282-0751 Fax: 423-282-1577 | |
Dr. Andrew Lee Gibson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-6111 Fax: 423-431-2910 | |
Clarence E Goulding Iii, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 200 Med Tech Pkwy, Suite 108, Johnson City, TN 37604 Phone: 423-915-5033 Fax: 423-952-3777 | |
Mark J Harrell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 378 Marketplace Dr, Suite 5, Johnson City, TN 37604 Phone: 423-282-0751 Fax: 423-282-1577 | |
Dr. Patricia L Chambers, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 325 N State Of Franklin Rd, Ground Floor, Johnson City, TN 37604 Phone: 423-439-7320 | |
Dr. Tracy Martin Reece, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 611 Toll Branch Rd, Johnson City, TN 37601 Phone: 423-773-9721 Fax: 423-743-2884 | |
Dr. Andrew S Pierce, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 408 N State Of Franklin Rd, Johnson City, TN 37604 Phone: 423-431-1810 Fax: 423-431-1811 |